Pharming Adds CDZ173 To Its Rare Disease Pipeline, Foresees Launch by 2022

 
• By Sten Stovall
Add_To_Cart
CDZ173 is in late-stage trials for treating APDS • Source: Shutterstock

More from Business

More from Scrip